Oral Bisphosphonate Use and Lung Cancer Incidence among Postmenopausal Women

被引：0
|
作者：
Tao, M. [1 ]
Chen, S. [1 ]
Freudenheim, J. L. [2 ]
Cauley, J. A. [3 ]
Johnson, K. C. [4 ]
Ma, X. [2 ]
Sarto, G. E. [5 ]
Wakelee, H. [6 ]
Boffetta, P. [7 ]
Wactawski-Wende, J. [2 ]
机构：
[1] Univ North Texas, Hlth Sci Ctr, Ft Worth, TX USA
[2] SUNY Buffalo, Buffalo, TX USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[5] Univ Wisconsin, Madison, WI USA
[6] Stanford Univ, Stanford, CA 94305 USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
D O I：
10.1016/j.jtho.2017.09.040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS02.02
引用
收藏
页码：S1564 / S1565
页数：2
相关论文
共 50 条
  • [1] Oral bisphosphonate use and lung cancer incidence among postmenopausal women
    Tao, M. H.
    Chen, S.
    Freudenheim, J. L.
    Cauley, J. A.
    Johnson, K. C.
    Mai, X.
    Sarto, G. E.
    Wakelee, H.
    Boffetta, P.
    Wactawski-Wende, J.
    ANNALS OF ONCOLOGY, 2018, 29 (06) : 1476 - 1485
  • [2] Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
    Chlebowski, Rowan T.
    Chen, Zhao
    Cauley, Jane A.
    Anderson, Garnet
    Rodabough, Rebecca J.
    McTiernan, Anne
    Lane, Dorothy S.
    Manson, JoAnn E.
    Snetselaar, Linda
    Yasmeen, Shagufta
    O'Sullivan, Mary Jo
    Safford, Monika
    Hendrix, Susan L.
    Wallace, Robert B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3582 - 3590
  • [3] Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer
    Newcomb, Polly A.
    Passarelli, Michael N.
    Phipps, Amanda I.
    Anderson, Garnet L.
    Wactawski-Wende, Jean
    Ho, Gloria Y. F.
    O'Sullivan, Mary Jo
    Chlebowski, Rowan T.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (10) : 1186 - 1190
  • [4] Orale Bisphosphonate und Brustkrebsinzidenz bei postmenopausalen FrauenOral bisphosphonate use and breast cancer incidence in postmenopausal women
    E.-F. Solomayer
    A. Rody
    Der Onkologe, 2011, 17 (6): : 536 - 538
  • [5] Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative
    Passarelli, Michael N.
    Newcomb, Polly A.
    LaCroix, Andrea Z.
    Lane, Dorothy S.
    Ho, Gloria Y. F.
    Chlebowski, Rowan T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (09) : 2043 - 2048
  • [6] Oral Bisphosphonates and Breast Cancer Incidence in postmenopausal Women
    Solomayer, E. -F.
    Rody, A.
    ONKOLOGE, 2011, 17 (06): : 536 - 537
  • [7] Reproductive Factors, Oral Contraceptive Use, And Lung Cancer Risk Among Postmenopausal Women: The Women's Health Initiative (WHI)
    Tran, B. T.
    Prentice, R. L.
    Chlebowski, R.
    Chien, J. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [8] Diabetes and Lung Cancer Among Postmenopausal Women
    Luo, Juhua
    Chlebowski, Rowan
    Wactawski-Wende, Jean
    Schlecht, Nicolas F.
    Tinker, Lesley
    Margolis, Karen L.
    DIABETES CARE, 2012, 35 (07) : 1485 - 1491
  • [9] Incidence of breast cancer among postmenopausal, hypertensive women
    Lindgren, Annamarja
    Pukkala, Eero
    Tuomilehto, Jaakko
    Nissinen, Aulikki
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 641 - 644
  • [10] Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study
    M. Pazianas
    B. Abrahamsen
    P. A. Eiken
    R. Eastell
    R. Graham G. Russell
    Osteoporosis International, 2012, 23 : 2693 - 2701
12345